Рет қаралды 60,358
UCLA urologist Robert Reiter, MD, discusses Ga-PSMA PET CT, a new method for detection and visualization of metastatic prostate cancer not previously visible with conventional and molecular imaging techniques. *Ga-PSMA PET CT is now offered at UCLA and aims to improve management of recurrent and high-risk cancers. Watch more webinars at www.uclahealth.org/uclamdchat.
PSMA is now FDA approved for use at UCLA and UCSF.